サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1449285

タクロリムス市場、シェア、市場規模、動向、産業分析レポート：製品タイプ別、最終用途別、地域別、セグメント別予測、2024年～203年

Tacrolimus Market Share, Size, Trends, Industry Analysis Report, By Product Type (Injections, Tablets and Capsules, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 203
出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
タクロリムス市場、シェア、市場規模、動向、産業分析レポート：製品タイプ別、最終用途別、地域別、セグメント別予測、2024年～203年
出版日: 2024年02月24日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、タクロリムス市場規模は2032年までに96億8,326万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

臓器移植率の増加がタクロリムス市場の成長を牽引しています。タクロリムスは、新たに移植された臓器の拒絶反応を防ぐために移植患者に広く使用されている強力な免疫抑制剤です。タクロリムス市場における医学研究と医薬品の継続的な進歩は、移植後の患者の転帰改善に大きく貢献しています。これらの開発は、タクロリムスの有効性を向上させただけでなく、免疫抑制に対するより的を絞った個別化アプローチの開発にもつながっています。移植後の臓器拒絶反応を予防するために使用される薬剤であるタクロリムスの入手可能性と入手しやすさが向上したことで、臓器移植率は好転しました。移植手順の簡素化や臓器提供に関する啓蒙活動も、タクロリムス市場の成長に寄与しています。

臓器移植手技の進歩がタクロリムス市場の成長を促進しています。低侵襲移植手技の進歩、臓器保存方法の改善、移植成功率の向上などにより、免疫抑制剤の必要性が高まっています。タクロリムスは、従来の薬剤に比べて効果が高く副作用が少ないため、移植医療において重要な薬剤として浮上しています。手術技術や移植後のケアの進歩に伴い、タクロリムスのような免疫抑制剤の使用が増加しています。タクロリムスの需要は、移植手術件数の増加や、様々な病状に対する効果的な治療法として移植が広く受け入れられていることから増加しています。

老年人口の増加に伴い、タクロリムスのような医薬品に対する需要も増加すると予想されます。高齢者は臓器移植を必要としたり、免疫関連疾患に直面したりすることが多いからです。ヘルスケアシステムは、この高齢者層の進化するヘルスケアニーズに対応するために適応しており、タクロリムスのメーカーやサプライヤーにとって大きな市場機会を生み出しています。

タクロリムス市場レポートハイライト

タクロリムスは患者にとって飲みやすく、服薬コンプライアンスが向上するため、錠剤・カプセル剤が2023年に最大の市場シェアを占めました。

臓器移植手術件数の増加により、2023年には免疫抑制剤が市場を独占しました。

北米は、臓器移植の急増と同地域の主要企業の存在により、タクロリムス市場を独占しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のタクロリムス市場に関する洞察

  • タクロリムス市場- エンドユースのスナップショット
  • タクロリムス市場力学
    • 促進要因と機会
      • 研究開発活動の増加がタクロリムス市場の成長を促進
      • 自己免疫疾患の有病率の増加が市場の成長を促進
    • 抑制要因と課題
      • タクロリムス市場の成長を妨げる副作用と代替治療法の利用可能性
  • PESTEL分析
  • タクロリムス市場の最終使用動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のタクロリムス市場、製品タイプ別

  • 主な調査結果
  • イントロダクション
  • 注射
  • 錠剤とカプセル
  • その他

第6章 世界のタクロリムス市場、用途別

  • 主な調査結果
  • イントロダクション
  • 皮膚炎
  • 免疫抑制
  • その他

第7章 世界のタクロリムス市場、エンドユース別

  • 主な調査結果
  • イントロダクション
  • クリニック
  • 病院
  • その他

第8章 世界のタクロリムス市場、地域別

  • 主な調査結果
  • イントロダクション
    • タクロリムス市場評価、地域別、2019-2032年
  • タクロリムス市場-北米
    • 北米：タクロリムス市場、製品タイプ別、2019-2032年
    • 北米：タクロリムス市場、エンドユース別、2019-2032年
    • 北米：タクロリムス市場、用途別、2019-2032年
    • タクロリムス市場-米国
    • タクロリムス市場- カナダ
  • タクロリムス市場- 欧州
    • 欧州：タクロリムス市場、製品タイプ別、2019-2032年
    • 欧州：タクロリムス市場、エンドユース別、2019-2032
    • 欧州：タクロリムス市場、アプリケーション別、2019-2032
    • タクロリムス市場- 英国
    • タクロリムス市場- フランス
    • タクロリムス市場- ドイツ
    • タクロリムスマーケット-イタリア
    • タクロリムス市場- スペイン
    • タクロリムス市場- オランダ
    • タクロリムス市場- ロシア
  • タクロリムス市場- アジア太平洋
    • アジア太平洋地域：タクロリムス市場、製品タイプ別、2019-2032年
    • アジア太平洋地域：タクロリムス市場、エンドユース別、2019～2032年
    • アジア太平洋地域：タクロリムス市場、用途別、2019-2032年
    • タクロリムス市場- 中国
    • タクロリムス市場- インド
    • タクロリムス市場- マレーシア
    • タクロリムス市場- 日本
    • タクロリムス市場- インドネシア
    • タクロリムス市場- 韓国
  • タクロリムス市場-中東およびアフリカ
    • 中東およびアフリカ：タクロリムス市場、製品タイプ別、2019-2032年
    • 中東およびアフリカ：タクロリムス市場、エンドユース別、2019-2032
    • 中東およびアフリカ：タクロリムス市場、用途別、2019-2032年
    • タクロリムス市場- サウジアラビア
    • タクロリムス市場- アラブ首長国連邦
    • タクロリムス市場- イスラエル
    • タクロリムス市場- 南アフリカ
  • タクロリムス市場-ラテンアメリカ
    • ラテンアメリカ：タクロリムス市場、製品タイプ別、2019-2032年
    • ラテンアメリカ：タクロリムス市場、エンドユース別、2019-2032
    • ラテンアメリカ：タクロリムス市場、用途別、2019-2032年
    • タクロリムス市場- メキシコ
    • タクロリムス市場- ブラジル
    • タクロリムス市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Astellas Pharma Inc
  • Biocon Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Inc
  • GlaxoSmithKline plc
  • LEO Pharma A/S
  • Novartis AG
  • Lupin Pharmaceuticals Inc.
  • Panacea Biotec
  • Pfizer Inc
図表

List of Tables

  • Table 1 Global Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 2 Global Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 4 Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 6 North America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 17 UK: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 18 UK: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 France: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 21 France: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 41 China: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 42 China: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 44 India: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 45 India: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Tacrolimus Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Tacrolimus Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product Type
  • Figure 9. Global Tacrolimus Market, by Product Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End-Use
  • Figure 11. Global Tacrolimus Market, by End-Use, 2022 & 2032 (USD Billion)
  • Figure 12. Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Tacrolimus Market
目次
Product Code: PM4519

The tacrolimus market size is expected to reach USD 9,683.26 million by 2032, according to a new study by Polaris Market Research. The report "Tacrolimus Market Share, Size, Trends, Industry Analysis Report, By Product Type (Injections, Tablets and Capsules, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing organ transplantation rates drive the tacrolimus market growth. Tacrolimus is a potent immunosuppressive drug extensively used in transplant patients to prevent the rejection of newly transplanted organs. The continuous advancements in medical research and pharmaceuticals within the tacrolimus market have significantly contributed to improving patient outcomes post-transplantation. These developments have not only enhanced the efficacy of tacrolimus but have also led to the development of more targeted and personalized approaches to immunosuppression. The increasing availability and accessibility of tacrolimus, a medication used to prevent organ rejection after transplantation, has led to a favorable increase in organ transplantation rates. Efforts to simplify transplantation procedures and educate the public on organ donation have also contributed to the tacrolimus market growth.

The advancements in organ transplantation procedures foster the tacrolimus market growth. The need for immunosuppressants has been on the rise due to advancements in minimally invasive transplant procedures, improved organ preservation methods, and higher success rates of transplants. Tacrolimus has emerged as a crucial medication in transplantation medicine because of its effectiveness and fewer side effects in comparison to traditional drugs. With advancements in surgical techniques and post-transplant care, the use of immunosuppressive drugs such as tacrolimus has increased. The demand for tacrolimus has increased due to the growing number of transplant surgeries and the wider acceptance of transplantation as an effective treatment for various medical conditions.

As the geriatric population grows, the demand for medications like tacrolimus is expected to increase. This is because older adults often require organ transplants or face immune-related disorders. Healthcare systems are adapting to meet the evolving healthcare needs of this aging demographic, creating a significant market opportunity for tacrolimus manufacturers and suppliers.

Tacrolimus Market Report Highlights

The tablets and capsules segment held the largest market share in 2023 due to tacrolimus being favorable and easy for patients to consume, ensuring better compliance with medication regimens.

The immunosuppression segment dominated the market in 2023 due to the rising number of organ transplant surgeries.

North America dominated the tacrolimus market, owing to the surge in organ transplants and the presence of the key players in the region.

The key market players include Astellas Pharma Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Inc., GlaxoSmithKline plc, LEO Pharma A/S, Novartis AG, Lupin Pharmaceuticals Inc., Panacea Biotec, and Pfizer Inc.

Polaris Market Research has segmented the tacrolimus market report based on product, application, end-use, and region:

Polypropylene Nonwoven Fabrics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Injections
  • Tablets and Capsules
  • Others

Polypropylene Nonwoven Fabrics, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Dermatitis
  • Immunosuppression
  • Others

Polypropylene Nonwoven Fabrics, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Clinics
  • Hospitals
  • Others

Polypropylene Nonwoven Fabrics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Global Tacrolimus Market Insights

  • 4.1.Tacrolimus Market - End-Use Snapshot
  • 4.2.Tacrolimus Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Increasing research and development activities drive the tacrolimus market growth
      • 4.2.1.2.The increasing prevalence of autoimmune diseases facilitating the growth of the market
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.Side effects and the availability of the alternative treatments hampering on the tacrolimus market growth
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTEL Analysis
  • 4.5.Tacrolimus Market End-Use Trends
  • 4.6.Value Chain Analysis
  • 4.7.COVID-19 Impact Analysis

5.Global Tacrolimus Market, by Product Type

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
  • 5.3.Injections
    • 5.3.1.Global Tacrolimus Market, by Injections, by Region, 2019-2032 (USD Billion)
  • 5.4.Tablets and Capsules
    • 5.4.1.Global Tacrolimus Market, by Tablets and Capsules, by Region, 2019-2032 (USD Billion)
  • 5.5.Others
    • 5.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)

6.Global Tacrolimus Market, by Application

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 6.3.Dermatitis
    • 6.3.1.Global Tacrolimus Market, by Dermatitis, by Region, 2019-2032 (USD Billion)
  • 6.4.Immunosuppression
    • 6.4.1.Global Tacrolimus Market, by Immunosuppression, by Region, 2019-2032 (USD Billion)
  • 6.5.Others
    • 6.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)

7.Global Tacrolimus Market, by End-Use

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
  • 7.3.Clinics
    • 7.3.1.Global Tacrolimus Market, by Clinics, By Region, 2019-2032 (USD Billion)
  • 7.4.Hospitals
    • 7.4.1.Global Tacrolimus Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.5.Others
    • 7.5.1.Global Tacrolimus Market, by Others, By Region, 2019-2032 (USD Billion)

8.Global Tacrolimus Market, by Geography

  • 8.1.Key findings
  • 8.2.Introduction
    • 8.2.1.Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3.Tacrolimus Market - North America
    • 8.3.1.North America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.2.North America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.3.3.North America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4.Tacrolimus Market - U.S.
      • 8.3.4.1.U.S.: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.3.4.2.U.S.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.4.3.U.S.: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5.Tacrolimus Market - Canada
      • 8.3.5.1.Canada: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.3.5.2.Canada.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.3.5.3.Canada: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.4.Tacrolimus Market - Europe
    • 8.4.1.Europe: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.2.Europe.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.4.3.Europe: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4.Tacrolimus Market - UK
      • 8.4.4.1.UK: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.4.2.UK.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.4.3.UK: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5.Tacrolimus Market - France
      • 8.4.5.1.France: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.5.2.France.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.5.3.France: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6.Tacrolimus Market - Germany
      • 8.4.6.1.Germany: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.6.2.Germany.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.6.3.Germany: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7.Tacrolimus Market - Italy
      • 8.4.7.1.Italy: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.7.2.Italy.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.7.3.Italy: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8.Tacrolimus Market - Spain
      • 8.4.8.1.Spain: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.8.2.Spain.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.8.3.Spain: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9.Tacrolimus Market - Netherlands
      • 8.4.9.1.Netherlands: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.9.2.Netherlands.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.9.3.Netherlands: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10.Tacrolimus Market - Russia
      • 8.4.10.1.Russia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.4.10.2.Russia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.4.10.3.Russia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.5.Tacrolimus Market - Asia Pacific
    • 8.5.1.Asia Pacific: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.2.Asia Pacific.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.5.3.Asia Pacific: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4.Tacrolimus Market - China
      • 8.5.4.1.China: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.4.2.China.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.4.3.China: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5.Tacrolimus Market - India
      • 8.5.5.1.India: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.5.2.India.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.5.3.India: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6.Tacrolimus Market - Malaysia
      • 8.5.6.1.Malaysia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.6.2.Malaysia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.6.3.Malaysia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7.Tacrolimus Market - Japan
      • 8.5.7.1.Japan: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.7.2.Japan.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.7.3.Japan: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8.Tacrolimus Market - Indonesia
      • 8.5.8.1.Indonesia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.8.2.Indonesia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.8.3.Indonesia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9.Tacrolimus Market - South Korea
      • 8.5.9.1.South Korea: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.5.9.2.South Korea.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.5.9.3.South Korea: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.6.Tacrolimus Market - Middle East & Africa
    • 8.6.1.Middle East & Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.2.Middle East & Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.6.3.Middle East & Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4.Tacrolimus Market - Saudi Arabia
      • 8.6.4.1.Saudi Arabia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.4.2.Saudi Arabia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.4.3.Saudi Arabia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5.Tacrolimus Market - UAE
      • 8.6.5.1.UAE: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.5.2.UAE.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.5.3.UAE: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6.Tacrolimus Market - Israel
      • 8.6.6.1.Israel: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.6.2.Israel.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.6.3.Israel: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7.Tacrolimus Market - South Africa
      • 8.6.7.1.South Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.6.7.2.South Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.6.7.3.South Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
  • 8.7.Tacrolimus Market - Latin America
    • 8.7.1.Latin America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.2.Latin America.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
    • 8.7.3.Latin America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4.Tacrolimus Market - Mexico
      • 8.7.4.1.Mexico: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.4.2.Mexico.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.4.3.Mexico: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5.Tacrolimus Market - Brazil
      • 8.7.5.1.Brazil: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.5.2.Brazil.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.5.3.Brazil: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6.Tacrolimus Market - Argentina
      • 8.7.6.1.Argentina: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
      • 8.7.6.2.Argentina.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
      • 8.7.6.3.Argentina: Tacrolimus Market, by Application, 2019-2032 (USD Billion)

9.Competitive Landscape

  • 9.1.Expansion and Acquisition Analysis
    • 9.1.1.Expansion
    • 9.1.2.Acquisitions
  • 9.2.Partnerships/Collaborations/Agreements/Exhibitions

10.Company Profiles

  • 10.1.Astellas Pharma Inc
    • 10.1.1.Company Overview
    • 10.1.2.Financial Performance
    • 10.1.3.Product Benchmarking
    • 10.1.4.Recent Development
  • 10.2.Biocon Ltd.
    • 10.2.1.Company Overview
    • 10.2.2.Financial Performance
    • 10.2.3.Product Benchmarking
    • 10.2.4.Recent Development
  • 10.3.Dr. Reddy's Laboratories Ltd.
    • 10.3.1.Company Overview
    • 10.3.2.Financial Performance
    • 10.3.3.Product Benchmarking
    • 10.3.4.Recent Development
  • 10.4.Glenmark Pharmaceuticals Inc
    • 10.4.1.Company Overview
    • 10.4.2.Financial Performance
    • 10.4.3.Product Benchmarking
    • 10.4.4.Recent Development
  • 10.5.GlaxoSmithKline plc
    • 10.5.1.Company Overview
    • 10.5.2.Financial Performance
    • 10.5.3.Product Benchmarking
    • 10.5.4.Recent Development
  • 10.6.LEO Pharma A/S
    • 10.6.1.Company Overview
    • 10.6.2.Financial Performance
    • 10.6.3.Product Benchmarking
    • 10.6.4.Recent Development
  • 10.7.Novartis AG
    • 10.7.1.Company Overview
    • 10.7.2.Financial Performance
    • 10.7.3.Product Benchmarking
    • 10.7.4.Recent Development
  • 10.8.Lupin Pharmaceuticals Inc.
    • 10.8.1.Company Overview
    • 10.8.2.Financial Performance
    • 10.8.3.Product Benchmarking
    • 10.8.4.Recent Development
  • 10.9.Panacea Biotec
    • 10.9.1.Company Overview
    • 10.9.2.Financial Performance
    • 10.9.3.Product Benchmarking
    • 10.9.4.Recent Development
  • 10.10.Pfizer Inc
    • 10.10.1.Company Overview
    • 10.10.2.Financial Performance
    • 10.10.3.Product Benchmarking
    • 10.10.4.Recent Development